Buy One Get One free -Llimited Time Offer X
Healthvit Clearclin Anti Acne Soap is primarily used for the treatment of Pimples. Secondary and off-label uses of Healthvit Clearclin Anti Acne Soap have also been mentioned below. The key ingredients of Healthvit Clearclin Anti Acne Soap are Neem, Aloe vera, Vitamin E, and Tea tree oil. The properties of which have been shared below. The correct dosage of Healthvit Clearclin Anti Acne Soap depends on the patient's age, gender, and medical history. This information has been provided in detail in the dosage section.
Neem |
|
Aloe vera |
|
Vitamin E |
|
Tea tree oil |
|
Healthvit Clearclin Anti Acne Soap is used to treat the following -
Main Benefits
Other Benefits
No side effects of Healthvit Clearclin Anti Acne Soap have been reported in the medical literature. However, you should always consult your doctor before using Healthvit Clearclin Anti Acne Soap.
Is the use of Healthvit Clearclin Anti Acne Soap safe for pregnant women?
Healthvit Clearclin Anti Acne Soap is safe to take during pregnancy.
Is the use of Healthvit Clearclin Anti Acne Soap safe during breastfeeding?
Healthvit Clearclin Anti Acne Soap is safe for breastfeeding women.
Is the use of Healthvit Clearclin Anti Acne Soap safe for children?
No research has been done regarding the safety of Healthvit Clearclin Anti Acne Soap for children. Therefore, it cannot be said if Healthvit Clearclin Anti Acne Soap is safe for children.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
Ministry of Health and Family Welfare. Department of Ayush: Government of India. [link]. Volume 2. Ghaziabad, India: Pharmacopoeia Commission for Indian Medicine & Homoeopathy; 1999: Page No - 131 - 135
Ministry of Health and Family Welfare. Department of Ayush: Government of India. [link]. Volume 1. Ghaziabad, India: Pharmacopoeia Commission for Indian Medicine & Homoeopathy; 1986: Page No 81-82
C.K. Kokate ,A.P. Purohit, S.B. Gokhale. [link]. Forty Seventh Edition. Pune, India: Nirali Prakashan; 2012: Page No 8.23-8.29